Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, Hurley J, Grad R, Latimer E, Perreault R, McLeod P, Huang A, Larochelle P, Mallet L.

JAMA. 2001 Jan 24-31;285(4):421-9.

PMID:
11242426
3.
5.

Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.

Wang PS, Patrick AR, Dormuth C, Maclure M, Avorn J, Canning CF, Schneeweiss S.

J Ment Health Policy Econ. 2010 Mar;13(1):37-44.

6.

Emergency department use and subsequent hospitalizations among members of a high-deductible health plan.

Wharam JF, Landon BE, Galbraith AA, Kleinman KP, Soumerai SB, Ross-Degnan D.

JAMA. 2007 Mar 14;297(10):1093-102. Erratum in: JAMA. 2008 Jan 9;299(2):171.

PMID:
17356030
7.
8.

Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.

Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR.

Med Care. 2008 Jun;46(6):565-72. doi: 10.1097/MLR.0b013e3181734a77.

PMID:
18520310
9.

Pharmacy benefits and the use of drugs by the chronically ill.

Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM.

JAMA. 2004 May 19;291(19):2344-50.

PMID:
15150206
10.

Prescription drugs: issues of cost, coverage, and quality.

Copeland C.

EBRI Issue Brief. 1999 Apr;(208):1-21.

PMID:
10539445
11.

The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.

Li X, Guh D, Lacaille D, Esdaile J, Anis AH.

Health Policy. 2007 Aug;82(3):340-7. Epub 2006 Nov 28.

PMID:
17134787
12.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
13.

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.

Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, Glynn RJ.

Clin Pharmacol Ther. 2003 Oct;74(4):388-400.

PMID:
14534526
14.

The impact of pharmacotherapy policy: a case study.

Tamblyn R.

Can J Clin Pharmacol. 2001 Fall;8 Suppl A:39A-44A. Review.

PMID:
11586378
15.

Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.

Dormuth CR, Maclure M, Glynn RJ, Neumann P, Brookhart AM, Schneeweiss S.

Clin Ther. 2008;30 Spec No:1038-50. doi: 10.1016/j.clinthera.2008.06.003.

16.
17.

Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments study.

Hsu J, Price M, Brand R, Ray GT, Fireman B, Newhouse JP, Selby JV.

Health Serv Res. 2006 Oct;41(5):1801-20.

18.

Ability to pay and the decision to medicate.

Stuart B, Grana J.

Med Care. 1998 Feb;36(2):202-11.

PMID:
9475474
19.

When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions.

Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM.

CMAJ. 2005 Nov 22;173(11):1335-40.

20.

Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.

Dormuth CR, Glynn RJ, Neumann P, Maclure M, Brookhart AM, Schneeweiss S.

Clin Ther. 2006 Jun;28(6):964-78; discussion 962-3.

PMID:
16860179
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk